Main Points:
– In October 2024, NASA’s Office of the Chief Health and Medical Officer (OCHMO) formed a working group to address venous thromboembolism (VTE) risks during spaceflight.
– The two-day meeting was held at NASA’s Johnson Space Center.
– The working group discussed research and clinical activities aimed at reducing VTE risk in astronauts during space missions.
Author’s Take:
NASA has taken a proactive approach by convening a working group to address the critical issue of venous thromboembolism (VTE) during space travel. By focusing on research and clinical activities, they demonstrate a commitment to ensuring the health and safety of astronauts on future missions. This initiative underscores NASA’s dedication to tackling health challenges associated with long-duration spaceflights.
Click here for the original article.